Re-evolving "therapeutics"
with software
Pioneering the field of digital therapeutics
We strive for the ideal of medical care,
a world where all people can receive high-quality treatment without worry.
Evolving treatment with the power of technology,
we will solve the social issues surrounding healthcare and realize ideal medical care.
COMPANY
Creating new therapeutic effects through technology
We develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs or devices were not effective. We aim to deliver the new treatment to as many patients as possible.
PRODUCT
Innovative treatment approach
Digital therapeutics opens the door to new intervention schemes without physical limitations (remotely at home, outside business hours). With the technology, we can realize effective personalized intervention through evidence-based personalized guidance promoting cognitive and behavioral changes.
Service Concept Service ListNEWS
2023.11.08
HT
Press
World’s first real-world data on the hypotensive effects of digital therapeutics
2022.08.17
Press
CureApp, Inc. and Sawai Group Holdings Co., Ltd. enter into a development and marketing license agreement for a DTx*1 solution in the NASH field
2022.08.16
Press
Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital Therapeutics Provider in Japan